Detection of disseminated prostate cells by reverse transcription- polymerase chain reaction (RT-PCR): Technical and clinical aspects

International Journal of Cancer

Volumn 77, Issue 5, 1998, Pages 655-673

  Corey, Eva ^a   Corey, Michael J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; TISSUE KALLIKREIN;

CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; STANDARDIZATION; TUMOR CELL;

ANTIGENS, SURFACE; BASE SEQUENCE; BONE NEOPLASMS; CARBOXYPEPTIDASES; DNA PRIMERS; EXONS; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; KALLIKREINS; MALE; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA-DIRECTED DNA POLYMERASE; TISSUE KALLIKREINS;

EID: 0031876939     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980831)77:5<655::AID-IJC1>3.0.CO;2-U     Document Type: Review

References (92)

1. CAMA, C., OLSSON, C.A., BUTTYAN, R., DE VRIES, G.M., WISE, G.J. and KATZ, A.E., Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J. Urol., 157, 1748-1751 (1997).
2. CAMA, C., OLSSON, C., RAFFO, A.J., PERLMAN, H., BUTTYAN, R., O'TOOLE, K., MCMAHON, D., BENSON, M.C. and KATZ, A.E., Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen. J. Urol., 153, 1373-1378 (1995).
3. CHELLY, J., CONCORDET, J., KAPLAN, J. and KAHN, A., Illegitimate transcription: Transcription of any gene in any cell type. Proc. nat. acad. Sci. (Wash.), 86, 2617-2621 (1989).
4. CHOMCZYNSKI, P. and SACCHI, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bioctem., 162, 156-159 (1987).
5. CLEMENTS, J. and MUKHTAR, A., Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. J. clin. Endocrinol. Metab., 78, 1536-1539 (1994).
6. COREY, E., ARFMAN, E.W., LIU, A.Y. and VESSELLA, R.L., Improved reverse transcriptase-polymerase chain reaction protocol with exogenous internal competitive control for prostate-specific antigen mRNA in blood and bone marrow. Clin. Chem., 43, 443-452 (1997a).
7. COREY, E., ARFMAN, E.W., OSWIN, M.M., MELCHIOR, S.W., TINDALL, D.J., YOUNG, C.Y.F., ELLIS, W.J. and VESSELLA, R.L., Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction (RT-PCR) of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Urology, 50, 184-188 (1997b).
8. DE CREMOUX, P., RAVERY, V., PODGORNIAK, M.P., CHEVILLARD, S., TOUBLANC, M., THIOUNN, N., TATOUD, R., DELMAS, V., CALVO, T. and BOCCON GIBOD, L., Value of the preoperative detection of prostate-specific-antigenpositive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy. Europ. Urol., 32, 69-74 (1997).
9. DEGUCHI, T. and 13 OTHERS, Detection of micrometastic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 53, 5350-5354 (1993).
10. DEGUCHI, T., YANG, M., EHARA, H., ITO, S., NISHINO, Y., TAKAHASHI, Y., ITO, Y., SHIMOKAWA, K., TANAKA, T., IMAEDA, T., DOI, T. and KAWADA, Y., Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer. Brit. J. Cancer, 75, 634-638 (1997).
11. DEGUCHI, T., YANG, M., NISHINO, Y., EHARA, H., TAKAHASHI, Y., KAWATA, Y., ITO, S., ITO, Y. and DOI, T., Molecular approach to detection of micrometastatic prostatic cancer cells in the lymph nodes and the bone marrow. Hinyokika. Kiyo, 42, 787-790 (1996).
12. DIAMANDIS, E.P., Prostate cancer, prostate-specific antigen, and the polymerase chain reaction [editorial; comment]. Clin. Chem., 1, 177-179 (1995).
13. DOHERTY, P.J., HUESCA-CONTRERAS, M., DOSCH, H.M. and PAN, S., Rapid amplification of complementary DNA from small amounts of unfractionated RNA. Anal. Biochem., 177, 7-10 (1989).
14. EDELSTEIN, R.A., KRANE, R.J., BABAYAN, R.K., DE LAS MORENAS, A. and MORELAND, R.B., A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription-polymerase chain reaction assay. Urology, 45, 597-603 (1995).
15. EDELSTEIN, R.A., ZIETMAN, A.L., DE LAS MORENAS, A., KRANE, R.J., BABAYAN, R.K., DALLOW, K.C., TRAISH, A. and MORELAND, R.B., Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology, 47, 370-375 (1996).
16. ELLIS, W.J., VESSELLA, R.L., COREY, E., ARFMAN, E.W., OSWIN, M.M., MELCHIOR, S. and LANGE, P.H., The value of a reverse-transcriptase polymerase chain reaction assay in patients with prostate cancer. J. Urol. 159, 1134-1138 (1998).
17. ENNIS, R.D., KATZ, A.E., DE VRIES, G.M., HEITJAN, D.F., O'TOOLE, K.M., RUBIN, M., BUTTYAN, R., BENSON, M.C. and SCHIFF, P.B., Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptasepolymerase chain reaction assay in patients with early stage prostate carcinoma. Independence from other pretreatment characteristics. Cancer, 79,2402-2408 (1997)
18. ESCHWÈGE, P., DUMAS, F., BLANCHET, P., MAIRE, V.L., BENOIT, G., JARDIN, A., LACOUR, B. and LORIC, S., Hematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet, 346, 1528-1530 (1995).
19. FADLON, E.J., REES, R.C., MCINTYRE, C., SHARRARD, R.M., LAWRY, J. and HAMDY, F.C., Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction. Brit. J. Cancer, 74, 400-405 (1996).
20. FAIR, W.R., ISRAELI, R.S. and HESTON, W.D., Prostate-specific membrane antigen. Prostate, 32, 140-148 (1997).
21. FERRARI, A.C., STONE, N.N., EYLER, J.N., GOA, M., MANDELI, J., UNGER, P., GALLAGHER, R.E. and STOCK, R., Prospective analysis of prostate specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J. nat. Cancer Inst., 89, 1498-1504 (1997).
22. FIDLER, I.J. and KRIPKE, M.L., Metastasis results from preexisting variant cells within malignant tumor. Science, 197, 893-895 (1977).
23. GALVAN, B., CHRISTOPOULOS, T.K. and DIAMANDIS, E.P., Detection of prostate-specific antigen mRNA by reverse transcription polymerase chain reaction and time-resolved fluorometry. Clin. Chem., 41, 11705-11709 (1995).
24. GHOSSEB, R.A., ROSAI, J., SCHER, H.I., SEIDEN, M., ZHANG, Z.F., SUN, M., CHANG, G., BERLANE, K., KRITHIVAS, K. and KANTOFF, P.W., Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral biood of patients with metastatic androgen-independent prostatic carcinoma. Urology, 50, 100-105 (1997).
25. GHOSSEIN, R.A., SCHER, H.I., GERALD, W.L., KELLY, W.K., CURLEY, T., AMSTERDAM, A., ZHANG, Z.F. and ROSAI, J., Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. J. clin. Oncol., 13, 1195-1200 (1995).
26. GOMELLA, L.G., RAJ, G.V. and MORENO, J.G., Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J. Urpl., 158, 326-337 (1997).
27. Gussow, D., REIN, R., GINJAAR, I., HOCHSTENBACH, F., SEEMANN, G., KOTTMAN, A. and PLOEGH, H.L., The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit. J. Immunol., 139, 3132-3138 (1987).
28. HARVEY, R.C., CLARK, T.J., MATSUBARA, K., RACETTE G.N., GROVHOUG, B.M., COREY, E. and VESSELA, R.L., Rapid and sensitive detection of prostate tumor cells in peripheral blood using transcription-mediated amplification (TMA) and hybridization protection assay (HPA) [abstract]. Abstract AACC (1996).
29. HENKE, W., JUNG, M., JUNG, K., LEIN, M., SCHLECHTE, H., BERNDT, C., RUDOLPH, B., SCHNORR, D. and LOENING, S.A., Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells [letter]. Clin. Chem., 42, 1499-1500 (1996).
30. HENKE, W., JUNG, M., JUNG, K., LEIN, M., SCHLECHTE, H., BERNDT, C., RUDOLPH, B., SCHNORR, D. and LOENING, S.A., Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int. J. Cancer, 70, 52-56 (1997).
31. HOROSZEWICZ, J.S., KAWINSKI, E. and MURPHY, G.P., Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res., 7, 927-936 (1987).
32. IGNATOFF, J.M., OEFELEIN, M.G., WATKIN, W., CHMIEL, J.S. and KAUL, K., Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. J. Urol., 158, 1870-1875 (1997).
33. ISRAELI, R.S., MILLER, W.H., Su, S.L., POWELL, C.T., FAIR, W.R., SAMADI, D.S., HURYK, R.F., DEBLASIO, A., EDWARDS, E.T., WISE, G.J. and HESTON, W.D.W., Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostatespecific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54, 6306-6310 (1994a).
34. ISRAELI, R.S., MILLER, W.H., SU, S.L., SMADI, D.S., POWEL, C.T., DEBLASIO, A., HURYK, R., FAIR, W.R., WISE, G.J. and HESTON, W.D.W., Sensitive detection of prostatic hematogenous micrometastasses using PSA and PSM-derived primers in the polymerase chain reaction. J. Urol., 153, 573-577 (1995).
35. ISRAELI, R.S., POWELL, C.T., CORR, J.G., FAIR, W.R. and HESTON, W.D.W., Expression of the prostate-specific membrane antigen. Cancer Res., 54, 1807-1811 (1994b).
36. ISRAELI, R.S., POWELL, C.T., FAIR, W.R. and HESTON, W.D.W., Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res., 53, 227-230 (1993).
37. JAAKKOLA, S., VORNANEN, T., LEINONEN, J., RANNIKKO, S. and STENMAN, U.H., Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate-specific antigen [see comments]. Clin. Chem., 41, 182-186 (1995).
38. KARRER, E.E., LINCOLN, J.E., HOGENHOUT, S., BENNETT, A.B., BOSTOCK, R.M., MARTINEAU, B., LUCAS, W.J., GILCHRIST, D.G. and ALEXANDER, D., In situ isolation of mRNA from individual plant cells: creation of cell-specific cDNA libraries. Proc. nat. Acad. Sci. (Wash.), 92, 3814-3818 (1995).
39. KATZ, A.E., DE VRIES, G.M., BEGG, M.D., RAFFO, A.J., CAMA, C., O'TOOLE, K., BUTTYAN, R., BENSON, M.C. and OLSSON, C.A., Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer, 75, 1642-1648 (1995).
40. KATZ, A.E., DE VRIES, G.M., BENSON, M.C., BUTTYAN, R.E., O'TOOLE, K., RUBIN, M.A., STIFELMAN, M. and OLSSON, C.A., The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy. Urol. Clin. North Amer., 23, 541-549 (1996).
41. KATZ, A.E., OLSSON, C.A., RAFFO, A.J., CAMA, C., PERLMAN, H., SEAMAN, E., O'TOOLE, K.M., MCMAHON, D., BENSON, M.C. and BUTTYAN, R., Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43, 765-775 (1994).
42. KAWAKAMI, M. and NAKAYAMA, J., Enhanced expression of prostatespecific membrane antigen gene in prostate cancer as revealed by in situ hybridization. Cancer Res,. 57, 2321-2324 (1997).
43. KAWAKAMI, M., OKANEYA, T., FURIHATA, K., NISHIZAWA, O. and KATSUYAMA, T., Detection of prostate cancer cells circulation in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res., 57, 4167-4170 (1997).
44. KLOBECK, H.G., COMBRIATO, G., SCHULTZ, P., ARBUSOW, V. and FITTLER, F., Genomic sequences of human prostate specific antigen (PSA). Nucleic Acids Res., 17, 3981 (1989).
45. KOMEDA, T., FUKUDA, Y., SANDO, T., KITA, R., FURUKAWA, M., NlSHlDA, N., AMENOMORI, M. and NAKAO, K., Sensitive detection of circulating hepato cellular carcinoma cells in peripheral venous blood. Cancer, 75, 2214-2219 (1995).
46. LAWN, R.M., EFSTRATIADIS, A., O'CONNELL, C. and MANIATIS, T., The nucleotide sequence of the human beta-globin gene. Cell, 21, 647-651 (1980).
47. LEHRER, S., TERK, M., PICCOLI, S.P., SONG, H.K., LAVAGNINI, P. and LUDERER, A.A., Reverse transcriptase-polymerase chain reaction for prostatespecific antigen may be a prognostic indicator in breast cancer. Brit. J. Cancer, 74, 871-873 (1996).
48. LEVESQUE, M., Hu, H., D'COSTA, M. and DIAMANDIS, E.P., Prostate-specific antigen expression by various tumors. J. Clin. Lab. Anal., 9, 123-128 (1995a).
49. LEVESQUE, M., Yu, H., D'COSTA, M., TADROSS, L. and DIAMANDIS, E.P., Immunoreactive prostate-specific antigen in lung tumors. J. clin. Lab. Anal., 9, 375-379 (1995b).
50. LINTULA, S. and STENMAN, U.H., The expression of prostate-specific membrane antigen in peripheral blood leukocytes. J. Urol., 157, 1969-1972 (1997).
51. LONGO, M.C., BERNINGER, M.S. and HARTLEY, J.L., Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions. Gene, 93, 125-128 (1990).
52. LORIC, S., DUMAS, F., ESCHWÈGE, P., BLANCHET, P., BENOIT, G., JARDIN, A. and LACOUR, B., Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen [see comments]. Clin. Chem., 41, 698-704 (1995).
53. LUNDWALL, A., Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. biophys. Res. Comm., 161, 1151-1159 (1989).
54. MELCHIOR, S.W., COREY, E., ELLIS, W.J., Ross, A.A., LAYTON, T.J., OSWIN, M.M., LANGE, P.H. and VESSELLA, R.L., Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin. Cancer Res., 3, 249-256 (1997).
55. MIES, C., A simple, rapid method for isolating RNA from paraffinembedded tissues for reverse transcription-polymerase chain reaction (RT-PCR). J. Histochem. Cytochem., 42, 811-813 (1994).
56. MIYAJIMA, Y., KATO, K., NUMATA, S. and HORIBE, K., Detection of neuroblastoma cells in bone marrow and peripheral blood at diagnosis by the reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA. Cancer, 75, 2757-2761 (1995).
57. MORENO, J.G., CROCE, C.M., FISCHER, R., MONNE, M., VIHKO, P., MULHOLLAND, S.G. and GOMELLA, L.G., Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52, 6110-6112 (1992).
58. MORENO, J.G., O'HARA, S.M., LONG, J.P., VELTRI, R.W., NING, X., ALEXANDER, A.A. and GOMELLA, L.G., Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology, 49, 515-520 (1997).
59. NAKAMURA, T. and 12 OTHERS, Esophageal metastasis from prostate cancer: diagnostic use of reverse transcriptase-polymerase chain reaction for prostate-specific antigen. J. Gastroenterol., 32, 236-240 (1997).
60. NGUYEN, C., DICKASON, R., SONG, W., YOUNG, C., TINDALL, D.J. and SLAWIN, K.M., RT-PCR for hK2 mRNA: a new assay for detecting circulating prostate cells. J. Urol., 157 (Suppl.), A436 (1997).
61. O'HARA, S.M., VELTRI, R.W. and SKIRPSTUNAS, P., Basal PSA mRNA levels detected by quantitative reverse transcriptase polymerase chain reaction (Q-RT-PCR-PSA) in blood from subjects without prostate cancer. J. Urol., 155 (SUPPL.), 430A (1996).
62. OEFELEIN, M.G., KAUL, K., HERZ, B., BLUM. M.D., HOLLAND, J.M., KEELER, T.C., COOK, W.A. and IGNATOFF, J.M., Molecular detection of prostate epithelial cells from the surgical field and peripheral circulation during radical prostatectomy. J. Urol., 155, 238-242 (1996).
63. OESTERLING, J., Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145, 907-923 (1991).
64. OLSSON, C.A., DE VRIES, G.M., BENSON, M.C., RAFFO, A., BUTTYAN, R., CAMA, C., O'TOOLE, K. and KATZ, A.E., The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. Brit. J. Urol., 77, 411-417 (1996a).
65. OLSSON, C.A., DE VRIES, G.M., RAFFO, A.J., BENSON, M.C., O'TOOLE, K., CAO, Y., BUTTYAN, R.E. and KATZ, A.E., Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 155, 1557-1562 (1996b).
66. OLSSON, C.A., DE VRIES, G.M., BUTTYAN, R. and KATZ, A.E., Reverse transcriptase-polymerase chain reaction assays for prostate cancer. Urol. Clin. North Amet., 24, 367-378 (1997).
67. PELKEY, T.J., FRIERSON, H.F. and BRUNS, D.E., Detection of micrometastases from solid tumors by use of immunological and molecular methods. Clin. Chem., 42, 1369-1381 (1996).
68. PONTE, P., NG, S.Y., ENGEL, J., GUNNING, P. and KEDES, L., Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta actin cDNA. Nucleic Acids Res., 10, 1687 (1984).
69. QIU, S., YOUNG, C.Y.F., BILHARTZ, D.L., PRESCOTT, J.L., FARROW, G.M., HE, W. and TINDALL, D.J., In situ hybridization of prostate-specific antigen mRNA in human prostate. J. Urol., 144, 1550-1556 (1990).
70. RAFF, T., VAN DER GIET, M., ENDEMANN, D., WIEDERHOLT, T. and PAUL, M., Design and testing of β-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques, 23, 456-460 (1997).
71. RIEGMAN, PH., KLAASEN, P. and VAN DER KORPUT, J.A., Molecular cloning and characterization of novel prostate antigen cDNAs. Biochem. biophys. Res. Comm., 155, 181-188 (1988).
72. SCHEDLICH, L.J., BENNETTS, B.H. and MORRIS, B.J., Primary structure of a human glandular kallikrein gene. DAM, 6, 429-437 (1987).
73. SCHOENFELD, A., KRUGER, K.H., GOMM, J., SlNNETT, H.D., GAZET, J.C., SACKS, N., BENDER, H.G., LUQMANI, Y. and COOMBES, R.C., The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Europ. J. Cancer, 33, 854-861 (1997).
74. SEIDEN, M.V., KANTOFF, P.W., KRITHIVAS, K., PROPERT, K., BRYANT, M., HALTOM, E., GAYNES, L., KAPLAN, I., BUBLEY, G., DEWOLF, W. and SKLAR, J., Detection of circulating tumor cells in men with localized prostate cancer. J. clin. Oncol., 12, 2634-2639 (1994).
75. SMITH, M.R., BIGGAR, S. and HUSSAIN, M., Prostate-specific antigen messenger RNA is expressed in non-prostate cells: implications for detection of micrometastases. Cancer Res., 55, 2640-2644 (1995).
76. SOKOLOFF, M.H., TSO, C., KABOO, R., NELSON, S., KO, J., DOREY, F., FIGLIN, R.A., PANG, S., DEKERNION, J. and BELLDEGRUN, A., Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 156, 1560-1566 (1996).
77. SU, S.L., HESTON, W.D., PERROTI, M., COOKSON, M.S., STROUMBAKIS, N., HUYRK, R., EDWARDS, E., BRANDER, B., COKE, J., SOLOWAY, S., LEWIS, A. and FAIR, W.R., Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction. Urology, 49, 95-101 (1997).
78. Su, S.L., HUANG, I.P., FAIR, W.R., POWELL, C.T. and HESTON, W.D., Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression. Cancer Res., 55, 1441-1443 (1995).
79. TALMADGE, J.E. and FIDLER, I.J., Cancer metastasis is selective or random depending on the parent tumour population. Nature (Lond.), 297, 593-596 (1982).
80. TAN, S.S. and WEIS, J.H., Development of a sensitive reverse transcriptase PCR assay, RT-RPCR, utilizing rapid cycle times. PCR Methods Appl., 2, 137-143 (1992).
81. THIOUNN, N., SAPORTA, F., FLAM, T.A., PAGES, F., ZERBIB, M., VIEILLEFOND, A., MARTIN, E., DEBRÉ, B. and CHEVILLARD, S., Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology, 50, 245-250 (1997).
82. VESSELLA, R.L., RILEY, D.E., BLOUKE, K.A., ARFMAN, E.W. and LANGE, PH., A sensitive method for detection of a prostate tumor cell marker using the polymerase chain reaction [abstract]. J. Urol., 147, 441A (1992).
83. WANG, X. and 14 OTHERS, Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann. Surg., 220, 768-774 (1994).
84. WERNERT, N., ALBRECH, M., SESTERHENN, I., GOEBBELS, R., BONKHOFF, H., SEITZ, G., INNIGER. R. and REMBERGER, K., The 'female prostate': location, morphology, immunohistochemical characteristics and significance. Europ. Urol., 22, 64-69 (1992).
85. WOOD, D.P. and BANERJEE, M., The presence on circulating prostate cells in the bone marrow of patients undergoing radical prostatecomy is predictive of disease-free survival. Micrometastases in patients with prostate cancer. J. clin. Oncol., 15, 3451-3457 (1997).
86. WOOD, D.P., BANKS, E.R., HUMPHREYS, S., MCROBERTS, J.W. and RANG NEKAR, V.M., Identification of bone marrow micrometastases in patients with prostate cancer. Cancer, 74, 2533-2540 (1994a).
87. WOOD, D.P., BANKS, E.R., HUMPHREYS, S. and RANGNEKAR, V.M., Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow. J. Histochem. Cytochem., 42, 505-511 (1994b).
88. YOUNG, C.Y.F., Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer Prostate, 7(Suppl.), 17-24 (1996).
89. ZARGHAMI, N. and DIAMANDIS, E.P., Detection of prostate-specific antigen mRNA and protein in breast tumors. Clin. Chem., 42, 361-366 (1996).
90. ZARGHAMI, N., LEVESQUE, M., D'COSTA, M., ANGELOPOULOU, K. and DIAMANDIS, E.P., Frequency of expression of prostate-specific antigen mRNA in lung tumors. Amer. J. clin. Pathol., 108, 184-190 (1997).
91. ZHANG, Y., ZIPPE, CD., VAN LENTE, F., KLEIN, E.A. and GUPTA, M.K., Combined nested reverse transcription-PCR assay for prostate-specific membrane antigen in detecting circulating prostatic cells. Clin. Cancer Res., 3, 1215-1220 (1997).
92. ZIPPELIUS, A., KUFER, P., HONOLD, G., KOLLERMANN, M. W., OBERNEDER, R., SCHILMOK, G., RIETHMÜLLER, G. and PANTEL, K., Limitations of reversetranscriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J. clin. Oncol., 15, 2701-2708 (1997).